Fundz

Nivagen Pharmaceuticals, Inc. reported raising $10 Million in an initial SEC Form D filing, from an offering of $10 Million

RECENTLY ACQUIREDSep 14, 2017

Amount Raised

$10 Million

$10 Million sold, per SEC Form D (first sale Sep 14, 2017)

Round Type

Venture

San FranciscoHealthcareSoftwareHealth Care

Quick answer

Nivagen Pharmaceuticals raised $10 Million in a funding round, dated September 14, 2017. Nivagen Pharmaceuticals is based in San Francisco, California, United States.

How much did Nivagen Pharmaceuticals raise?
Nivagen Pharmaceuticals raised $10 Million in a funding round on September 14, 2017.
What does Nivagen Pharmaceuticals do?
Nivagen Pharmaceuticals, Inc. is a specialty pharmaceutical company founded in 2009 and headquartered in Sacramento, California, focused on developing and manufacturing ready-to-use sterile injectables and complex..
Where is Nivagen Pharmaceuticals based and how big is it?
Nivagen Pharmaceuticals is based in San Francisco, California, United States. Fundz records about 150 employees.
Who are the decision-makers at Nivagen Pharmaceuticals?
Fundz holds 3 contacts at Nivagen Pharmaceuticals, including the Vice President Research and Development. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Software around the same time

Companies in the same sectors as Nivagen Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.

  • Headspace raised $39M on October 26, 2017.
  • Blueprint raised an undisclosed amount on October 24, 2017.
  • Zenflow raised $11M on October 6, 2017.
  • Recursion Pharmaceuticals raised $56M on October 6, 2017.
  • Vero Biotech Inc. raised $30M on September 29, 2017.
  • BrainScope raised $16M on September 29, 2017.

Who to call at Nivagen Pharmaceuticals, and when

A new round usually means Nivagen Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Nivagen Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Nivagen Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Nivagen Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Nivagen Pharmaceuticals

Location

3100 FITE CIRCLE

San Francisco, California, United States

About

Nivagen Pharmaceuticals, Inc. is a specialty pharmaceutical company founded in 2009 and headquartered in Sacramento, California, focused on developing and manufacturing ready-to-use sterile injectables and complex dosage forms through its advanced aseptic manufacturing capabilities.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Nivagen Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsNirav P., Vice President Research and Development hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Nivagen Pharmaceuticals's next move

See what Strategic adds

Nivagen Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.